Most Recent

image: Jason Holliday: Tree Tracker

Jason Holliday: Tree Tracker

By | February 1, 2016

Associate Professor, Virginia Tech, Department of Forest Resources and Environmental Conservation. Age: 37

0 Comments

image: Surrogate Genes Enable Reproduction

Surrogate Genes Enable Reproduction

By | January 28, 2016

Increasing the expression of two genes from non-Y chromosomes restores spermatogenesis in male mice that lack Y chromosomes.

2 Comments

image: Schizophrenia and the Synapse

Schizophrenia and the Synapse

By | January 27, 2016

Genetic evidence suggests that overactive synaptic pruning drives development of schizophrenia.

5 Comments

image: More CRISPR Improvements

More CRISPR Improvements

By | January 25, 2016

Researchers at the University of California, Berkeley, boost the CRISPR/Cas9 system’s gene-editing success rate in short pieces of DNA.

0 Comments

image: Nutrient-Control for GM Bacteria

Nutrient-Control for GM Bacteria

By | January 20, 2016

Genetically modified bacteria that don’t survive unless given an unnatural amino acid could serve as a new control measure to protect wild organisms and ecosystems against accidental release. 

1 Comment

image: Another Role for ApoE?

Another Role for ApoE?

By | January 20, 2016

Key Alzheimer’s disease–related protein may be a transcriptional regulator.

3 Comments

image: Mutant Mosquitoes Deployed to Stop Zika, Dengue

Mutant Mosquitoes Deployed to Stop Zika, Dengue

By | January 19, 2016

A Brazilian town will ramp up the release of insects engineered to shrink mosquito populations.

0 Comments

image: GM Paper Flagged by Politician Retracted

GM Paper Flagged by Politician Retracted

By | January 18, 2016

One of three suspect publications from a group of scientists in Italy is pulled for plagiarism while an investigation is ongoing.

0 Comments

image: $280 Million Boost for Disease Genomics

$280 Million Boost for Disease Genomics

By | January 18, 2016

The genomics arm of the National Institutes of Health has pledged a total of $280 million for research into the genetic bases of disease.

0 Comments

image: Shire to Buy Baxalta for $32 Billion

Shire to Buy Baxalta for $32 Billion

By | January 12, 2016

The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.

0 Comments

Popular Now

  1. Exercise Boosts Telomere Transcription
  2. Neurons Compete to Form Memories
  3. Classic Example of Symbiosis Revised
  4. The Genetic Components of Rare Diseases
RayBiotech